Skip to Content

Rifabutin

In the US, Rifabutin (rifabutin systemic) is a member of the drug class rifamycin derivatives and is used to treat Mycobacterium avium-intracellulare - Prophylaxis, Mycobacterium avium-intracellulare - Treatment, Tuberculosis - HIV Positive and Tuberculosis - Prophylaxis.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J04AB04

CAS registry number (Chemical Abstracts Service)

0072559-06-9

Chemical Formula

C46-H62-N4-O11

Molecular Weight

847

Therapeutic Categories

Antibacterial

Antitubercular agent

Chemical Name

(9S,12E,14S,15R,16S,17R,18R,19R,20S,21S,22E,24Z)-6,16,18,20-Tetrahydroxy-1'-isobutyl-14-metoxy-7,9,15,17,19,21,25-heptametylspiro[9,4-(epoxypentadeca[1,11,13]trienoimino)-2H-furo[2',3':7,8]napht[1,2-d]imidazole-2,4'-piperidine]-5,10,26-(3H,9H)-trione 16-a (WHO)

Foreign Names

Generic Names

  • Rifabutin (OS: BAN, USAN, JAN)
  • Rifabutina (OS: DCIT)
  • Rifabutine (OS: DCF)
  • Ansamicin (IS)
  • Ansamycin (IS)
  • LM 427 (IS: FarmitaliaCarl)
  • Rifabutin (PH: BP 2016, Ph. Eur. 8, USP 38)
  • Rifabutine (PH: Ph. Eur. 8)
  • Rifabutinum (PH: Ph. Eur. 8)

Brand Names

  • Ansatipin
    Pfizer, Spain; Pfizer, Finland; Pfizer, Sweden
  • Ansatipine
    SERB Laboratoires, France
  • Macbutin
    Macleods, India
  • Mycobutin
    Pfizer, Austria; Pfizer, Australia; Pfizer, Belgium; Pfizer, Canada; Pfizer, Switzerland; Pfizer, Czech Republic; Pfizer, United Kingdom; Pfizer, Hong Kong; Pfizer, Ireland; Pfizer, Israel; Pfizer, Netherlands; Pfizer, New Zealand; Pfizer, Portugal; Pfizer, Turkey; Pfizer, Taiwan; Pfizer, South Africa; Pfizer Italia, Italy; Pfizer Japan, Japan; Pharmacia & Upjohn, United States
  • Ributin
    Lupin, India
  • Rifabutin Pfizer
    Pfizer, Denmark
  • Tambux
    Richmond, Argentina

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide